Skip to content
← All startups
Abselion logo

Abselion

Series A

Provider of a benchtop instrument for protien research. It offers Amperia which is integrated with 96-well plates and based on Redox Electrochemical Detection technology that tracks electrical alterations when interacted with molecules for antibody quantification or binding assays.

Life Sciences · Life Sciences Platforms and Tools · Cambridge, United Kingdom · EST 2018

About

Provider of a benchtop instrument for protien research. It offers Amperia which is integrated with 96-well plates and based on Redox Electrochemical Detection technology that tracks electrical alterations when interacted with molecules for antibody quantification or binding assays.

Institutional investors

University of CambridgeParkwalkNew Ground VenturesR42 GroupSwiss Health AngelsM VenturesBioProcess360UNTITLEDBGFCambridge AngelsThe Untitled VenturesCambridge Enterprise

Latest coverage

📰 Browse funding news — rounds, valuations, and market moves for founders.

Backed by funds in our directory

🗂️ Full list of active funds — filter by stage, check size, and geography.

Raising like Abselion?

Analyze your pitch deck before your next raise.

Analyze My Deck →